|Working Paper 162||“All offices” experience of term assurances in 2020 (Issue date: 20/05/2022)|
|Working Paper 154||Final “16” Series term assurance mortality and accelerated critical illness tables (Issue Date: 31/08/2021)|
|Working Paper 152||
“All offices” experience of term assurances for 2015-2018 and 2019 plus indicative analysis of experience to mid-2020 (Issue date: 29/06/2021)
|Working Paper 151||
Accelerated critical illness experience by cause of claim, 2015-2018 (Issue Date: 11/06/2021)
|Working Paper 150||Proposed “16” Series term assurance mortality and accelerated critical illness tables (Issue Date: 30/04/2021; Response date: 30/06/2021)|
|Working Paper 132||“All offices” experience of term assurances, 2015-2018 (Issue date: 07/05/2020; v02 issue date: 29/04/2021; v03 issue date: 29/06/2021)|
|Working Paper 125||Additional analysis of the experience of term assurances, 2011-2016 (Issue date: 15/11/2019)|
|Working Paper 123||
"All offices” experience of term assurances, 2011-2016 (v01: issue date: 18/07/2019; v02 issue date: 07/05/2020)
|Working Paper 110||Working Paper 110: Using the CMI Mortality Projections Model for assured lives (Issue date: 04/10/2018; Response date: 31/12/2018)|
|Working Paper 108||Interim “all offices” experience of term assurances, 2011-2015 (v01 issue date: 08/06/2018; v02 issue date: 07/05/2020; Response date: 12/07/2018)|
|Working Paper 94||Final "08" Series accelerated critical illness and term mortality tables (Issue date: 27/01/2017)|
|Working Paper 92||Proposed "08" Series term mortality tables (Issue Date: 07/10/2016; Response date: 30/11/2016)|
|Proposed "08" Series accelerated critical illness tables (Issue date: 06/05/2016; Reissued: 07/10/2016; Response date: 30/11/2016)|
|All-Offices Mortality and Critical Illness Experience for the 2007-2010 Quadrennium (Issue date: 03/12/2014; Reissued: 01/02/2016)|
|A revised approach for analysing CMI critical illness experience and restated results for accelerated business, 2003-2006 (Issue date: 10/05/2013)|
|Supplementary analyses to CMI critical illness diagnosis rates for accelerated business, 2003-2006|
|Cause-specific CMI critical illness diagnosis rates for accelerated business, 2003-2006 (Issue date: 15/06/2011)|
|CMI critical illness diagnosis rates for accelerated business 2003-2006 (Issue date: 24/01/2011)|
|CMI critical illness diagnosis rates for accelerated business 1999-2004 (Issue date: 12/02/2010)|
|The mortality of impaired assured lives: Report on 1995-2006 experience and consultation on the future of the investigation (Issue date: 14/01/2009)|
|A new methodology for analysing CMI critical illness experience (Issue date: 23/07/2008)|
|Progress towards an improved methodology for analysing CMI critical illness experience (Issue date: 27/07/2007)|
|1999-2002 critical illness experience: feedback on Working paper 14 and future work (Issue date: 01/12/2005)|
|Methodology underlying the 1999-2002 CMI critical illness experience investigation (Issue date: 05/05/2005)|
|The graduation of the CMI 1999-2002 mortality experience: feedback on Working paper 8 and proposed assured lives graduations (Issue date: 11/04/2005)|
If you have any questions about the CMI please email
Filter or search events
The purpose of this research paper is to explore enterprise risk management lessons which can be learnt from the Covid-19 pandemic in preparation for potential future pandemics as well as other “gray rhino” or “black swan” events. This paper is not intended to be an all-encompassing solution to the issues presented by Covid-19; rather, the content has been provided to help drive discussions regarding how risk management processes may need to evolve in line with the dynamic nature of the underlying risks that they sometimes need to capture.
This webinar will discuss good exam technique, including various approaches candidates can take in managing their time completing their exams in the online format.
This session is for new candidates and existing candidates where we will be discussing the practical steps you need to take leading up your exam and on the day. We will be discussing how to testing the online exam platform, downloading and uploading your paper and key information from the Exam Handbook.
The exam webinar is for candidates, new to IFoA exams and returning candidates, sitting in the September 2022 exam session.
The role of Non-Executive Directors has become increasingly challenging and critical over the past few years.
Big picture thinking, Governance knowledge, Independent mindset, Ambassador potential and Energy and commitment: these are the essential skills sought in a successful NED, according to the Chartered Governance Institute (UK & Ireland).
In parallel, Environmental, Social and Governance (ESG) criteria are increasingly key and used by investors to measure the sustainability and ethical impact of investing in an organisation.
This webinar will cover:
• Some background on the risks of misselling in an ESG context, including the DWS case
• Achieving positive impact is a strong antidote to the risks of greenwashing or ESG misselling, however this risks having a tension with fiduciary responsibilities
• This tension can be resolved with a concept called Universal Ownership
• Under Universal ownership, investors have an appetite to make a loss in order to achieve positive impact, and yet still have no compromise on their fiduciary responsibilities
In the UK, the idea of collective defined contribution (CDC) pension schemes is gaining more attention with the launch of the Royal Mail CDC scheme, the first of its kind in the UK. Our recent research on CDC plans investigates the sources of the putative benefits of CDC schemes: the smoothing of pensions for members. Using an attribution analysis to burrow into the scheme design, the reason for the smoothing of members' pensions is explained and understood.
The IFoA's Infrastructure Working Party, led by Chris Lewin, will present its new introductory guide to infrastructure investment, which will be published on the IFoA web-site prior to the webinar. Those readers whose institutions have already taken the plunge into infrastructure will know that it is a highly complex and diverse field of activity. This guide does not explore all the matters which investors take into account, but it does discuss many of the more important points, including the risks and past returns, benchmarking, and ESG and SDG considerations. Attendees will be invi
Social care reform has long been on the to-do list for successive governments over the last two decades. In February, the government’s proposed reforms to adult social care [including cap on care costs] was published. Against this backdrop of funding promise and rising National Insurance taxation, in this session we will debate the resilience of these new proposals, the impact of future demand for care services and what role for the insurance industry and the important role it has played in long-term care funding in other countries where public-private partnership works.
Health contributes to happiness at the personal, family, community and societal level. Health, importantly underpins all our economic security. This talk will explore the drivers of our health, the measurement of health and the steps we can take to improve health – most of which lie outside the NHS.
We are delighted to announce the return of GIRO as an in-person conference, giving you an opportunity to connect with actuaries in your practice area. Join leading experts to discuss key issues, emerging ideas, and new research across the General Insurance sector.
Life Conference returns as an in-person conference in 2022, giving you an opportunity to connect with your peers and fellow actuaries in your sector, in person. You will also hear leading experts discuss key issues, emerging ideas, and new research across the Life insurance sector.
Mortality and morbidity risk varies by variables such as age, sex and smoking. In traditional actuarial experience analysis, these variables, and certain combinations thereof can be explored. However, with the wealth of data now available it is becoming increasingly challenging to identify the key drivers of experience and account for the interaction between different variables. A univariate approach often compares apples and pears, for example males are more likely to smoke and have larger policies than females. Likewise, variable interactions are missed unless specifically included.